The following topics have been updated since your last alert
Go to the NICE website for details http://www.nice.org.uk/guidance/index.jsp?action=byType&type=2&status=3
Acute coronary syndrome - rivaroxaban [ID532]
Anaemia (cancer-treatment induced) - erythropoiesis-stimulating agents (epoetin and darbepoetin) (inc rev TA142) [ID541]
Bronchiolitis
Cholelithiasis and cholecystitis
Electrochemotherapy for the treatment of skin cancers (basal cell and squamous cell carcinoma)
Hypercholesterolemia - mipomersen [ID524]
Magec Growth Rod for non-invasive spinal lengthening in children with early onset scoliosis
Malignant melanoma
Mental health problems in people with learning disability
Rheumatoid arthritis - adalimumab, etanercept, infliximab (TA130), certolizumab pegol (TA186), golimumab (TA225 part review), & tocilizumab (TA247) - review [ID537]
Rheumatoid arthritis - tofacitinib [ID526]
Schizophrenia or bipolar disorder - loxapine [ID479]
Transfusion
Acute upper GI bleeding
Autism in adults
Breast cancer (metastatic hormone-receptor) - lapatinib and trastuzumab (with aromatase inhibitor)
Lung cancer (non small cell, EGFR-TK mutation positive) - erlotinib (1st line)
Migraine (chronic) - botulinum toxin type A
Prevention and control of healthcare-associated infections
Prostate cancer (metastatic, castration resistant) - abiraterone (following cytoxic therapy)
Sickle cell acute painful episode
Venous thromboembolic diseases
No comments:
Post a Comment